Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS) is a Healthcare stock tracked by StreetAlpha. It last closed at $7.38 on Oct 5. EBS reports earnings on Wed, Nov 4, 2026. The average 12-month price target from 2 analysts is $13.00 (+76.2% from the last close), with a high of $16.00 and a low of $10.00.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 2 analysts who set a price target on EBS in the past 90 days. The average target is $13.00, with a high of $16.00 and a low of $10.00, compared with the last close of $7.38.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 25 | Rodman & Renshaw | Initiated | Buy | $16 |
| Aug 10 | HC Wainwright & Co. | Maintained | Buy | $10 |
Whale Options Flow
90DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether EBS is in one of them and how their past EBS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered EBS in an article yet. Here's the latest on the wider market.
EBS Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Steve CohenD · TN | Sell | $1K – $15K | Dec 11, 2024 | Jan 10, 2025 | 30 d |
| Josh GottheimerD · NJ | Sell | $1K – $15K | Nov 5, 2021 | Dec 13, 2021 | 38 d |
| Josh GottheimerD · NJ | Buy | $1K – $15K | Oct 18, 2021 | Nov 15, 2021 | 28 d |
| Josh GottheimerD · NJ | Sell (partial) | $1K – $15K | Sep 15, 2021 | Oct 13, 2021 | 28 d |
| Josh GottheimerD · NJ | Sell (partial) | $1K – $15K | Feb 23, 2021 | Mar 10, 2021 | 15 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.